Term
| what are the two monoclonal Ab's that target EGFR? |
|
Definition
| Cetuximab and Panitumumab |
|
|
Term
| Which monoclonal Ab has the longest half life? |
|
Definition
|
|
Term
| This monoclonal Ab has allergic reaction and HACA |
|
Definition
|
|
Term
| This monoclonal Ab is used for head and neck cancer |
|
Definition
|
|
Term
| This drug inhibits tyrosine kinase |
|
Definition
|
|
Term
| What two drugs target HER2? |
|
Definition
| Trastuzumab and Lapatinib |
|
|
Term
| Which HER2 target drug cause myocardial dysfunction and HAHA? |
|
Definition
|
|
Term
| This HER2 target drug comes in oral form ONLY |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| This drug causes hand and foot syndrome |
|
Definition
|
|
Term
| This drug recognizes all forms of VEGF |
|
Definition
|
|
Term
| These 2 drugs target angiogenesis |
|
Definition
|
|
Term
| Which VEGF target drug has the longest half-life |
|
Definition
|
|
Term
| This drug targets proteasomes (chymotrypsin) |
|
Definition
|
|
Term
| These 2 drugs are immunomodulatory and anti-angiogenic |
|
Definition
| Thalidomide and Lenalidomide |
|
|
Term
| This immunomodulatory drug treats ENL |
|
Definition
|
|
Term
| Which immunomodulatory drug is a teratogen |
|
Definition
|
|
Term
| Which immunomodulatory drug causes thrombocytopenia |
|
Definition
|
|
Term
| This monoclonal Ab presents w/hypomagnesia |
|
Definition
|
|
Term
| This drug causes a complete hematologic response |
|
Definition
|
|
Term
| This is the first drug for liver cancer |
|
Definition
|
|
Term
| This targets the intracellular portion of TK receptor of VEGFR-2 |
|
Definition
|
|
Term
| This immunomodulatory agent possesses also anti-NEOPLASTIC properties |
|
Definition
|
|
